Quand? 01.06.2024
8:45 AM: Welcome
Chair: Serge Rozenberg - ULB
9:00 AM: Physiopathology of vasomotor symptoms (Axelle Pintiaux - U Liège) 9:30 AM: Why, how and when not using MHT? (Linda Ameryckx - UZ Antwerp) 10:00 AM: Brain effects of anti-hormones: Herman Depypere (UZ Ghent) 10-10:30 AM: Coffee & visit to booths
10-30 AM: When can hormone NOT be used? (Axelle Pintiaux - U Liège)
The meeting will be followed by the ‘Astellas Satellite meeting’
11.00-12.00 AM: Fezolinetant (VEOZATM): Are NK3R inhibitors a new paradigm in the management of menopause related VMS?
• Introduction and moderator: dr Linda Ameryckx - UZ Antwerp
• NK3 Receptors/Thermoregulation and Fezolinetant - mode of action: prof Herman Depypere - UZ Ghent • Clinical data from the Phase III SKYLIGHT studies: prof. Serge Rozenberg (ULB - Brussels)
• Conclusions & Take home messages: dr. Linda Ameryckx - UZ Antwerp
